Article
Bedaquiline resistance probability to guide treatment decision making for rifampicin-resistant tuberculosis - insights from a qualitative study
2022-09-23
Abstract excerpt
<h4>Background: </h4> Bedaquiline (BDQ) is a core drug for rifampicin-resistant tuberculosis (RR-TB) treatment. Accurate prediction of a BDQ-resistant phenotype from genomic data is not yet possible. A Bayesian method to predict BDQ resistance probability from next-generation sequencing data has been proposed as an alternative. <h4>Methods: </h4> We performed a qualitative study to investigate the decision-making...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 388ab380-0896-53f2-b9a3-4959dc0889f7
- DOI
- 10.21203/rs.3.rs-2041161/v1
